97 Results

People

  1. Motzer
    Motzer
  2. Abou-Alfa
    Abou-Alfa
  3. Aghajanian
    Aghajanian
  4. Kris
    Kris
  5. Chou
    Chou
  6. Dickler
    Dickler
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Mulhall
    Mulhall
  10. Vickers
    Vickers

Groups

  1. Department of Medicine (58)
  2. Solid Tumor Oncology Division (49)
  3. Genitourinary Oncology Service (15)
  4. Surgery (14)
  5. Survivorship Research (11)
  6. GDMT, Medicine (10)
  7. Gynecologic Medicine Service (10)
  8. Gynecology Disease Management Team (10)
  9. Gastrointestinal Oncology Service (9)
  10. Hematologic Malignancies, Division of (9)
  1. "double-blind"
Formats
  1. Journal Article (74)
  2. Review (9)
  3. Guidelines (5)
  4. Book Section (4)
  5. Conference Paper (2)
  6. Editorial (2)
  7. Meeting Abstract (1)
Groups
  1. Department of Medicine (58)
  2. Solid Tumor Oncology Division (49)
  3. Genitourinary Oncology Service (15)
  4. Surgery (14)
  5. Survivorship Research (11)
  6. GDMT, Medicine (10)

More Groups

People
  1. Robert Motzer (5)
  2. Carol Aghajanian (4)
  3. Ghassan Abou-Alfa (4)
  4. Mark Kris (4)
  5. Andrew Vickers (3)
  6. Clifford Hudis (3)

More People

Years
  1. 2025 (5)
  2. 2024 (3)
  3. 2023 (6)
  4. 2022 (8)
  5. 2021 (7)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. Annals of Oncology (4)
  3. New England Journal of Medicine (4)
  4. Oncology (Norwalk) (4)
  5. Anesthesia and Analgesia (3)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (20)
  2. Oxford University Press (10)
  3. Lippincott Williams & Wilkins (8)
  4. Elsevier Inc. (6)
  5. American Association for Cancer Research (4)
  6. C M P Medica LLC * The Oncology Group (4)

More Publishers

Results (97)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab
    Journal Article

    Nixon, A. B.; Liu, Y. M.; Yang, Q.; Luo, B.; Starr, M. D.; Brady, J. C.; Kelly, W. K.; Beltran, H.; Morris, M. J.; George, D. J.; more...
    Prostate Cancer and Prostatic Diseases (2025)

    Fulltext@MSK | Save
  • Clinical and translational results from PORTER, a multicohort phase I platform trial of combination immunotherapy in metastatic castration-resistant prostate cancer
    Journal Article

    Galsky, M. D.; Autio, K. A.; Cabanski, C. R.; Wentzel, K.; Graff, J. N.; Friedlander, T. W.; Howes, T. R.; Shotts, K. M.; Densmore, J.; Spasic, M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Treatment of pleural mesothelioma: ASCO guideline update
    Guidelines

    Kindler, H. L.; Ismaila, N.; Bazhenova, L.; Chu, Q.; Churpek, J. E.; Dagogo-Jack, I.; Bryan, D. S.; Drazer, M. W.; Forde, P.; Husain, A. N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Perioperative pain management in patients with cancer-related pain: A narrative review
    Review

    Horine, S. V.; Rakesh, N.; Nadav, D.; Gulati, A.
    Anesthesia and Analgesia (2025)

    Fulltext@MSK | Save
  • Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer
    Journal Article

    Konda, B.; Sherman, E. J.; Massarelli, E.; Nieva, J.; Muzaffar, J.; Morris, J. C., III; Ryder, M.; Ho, A. L.; Agulnik, M.; Wei, L.; more...
    Journal of Clinical Endocrinology and Metabolism (2025)

    Fulltext@MSK | Save
  • Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and in combination with targeted therapy in estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Phase Ia/Ib EMBER study
    Journal Article

    Jhaveri, K. L.; Lim, E.; Jeselsohn, R.; Ma, C. X.; Hamilton, E. P.; Osborne, C.; Bhave, M.; Kaufman, P. A.; Beck, J. T.; Sanchez, L. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Gabapentin and rapidity of recovery among patients undergoing minimally invasive ambulatory uro-oncologic surgeries
    Journal Article

    Kohilakis, E.; Assel, M.; Serafin, J.; Mehta, M.; McCready, T. M.; Tokita, H. K.; McCormick, P. J.; Vickers, A. J.; Carlsson, S. V.; Laudone, V. P.; more...
    Urology Practice (2024)

    Fulltext@MSK | Save
  • PHOCUS: A phase 3, randomized, open-label study of sequential treatment with pexa-vec (JX-594) and sorafenib in patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Galle, P. R.; Chao, Y.; Erinjeri, J.; Heo, J.; Borad, M. J.; Luca, A.; Burke, J.; Pelusio, A.; Agathon, D.; more...
    Liver Cancer (2024)

    Fulltext@MSK | Save
  • Niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer
    Journal Article

    Chi, K. N.; Rathkopf, D.; Smith, M. R.; Efstathiou, E.; Attard, G.; Olmos, D.; Lee, J. Y.; Small, E. J.; Gomes, Ajpds; Roubaud, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Is there a pathway for phosphatidylinositol 3-kinase delta inhibitors to be approved therapeutics for B-cell lymphoma therapy
    Editorial

    Luttwak, E.; Smith, M. R.; Zelenetz, A. D.
    Expert Opinion on Pharmacotherapy (2023)

    Fulltext@MSK | Save